(NASDAQ: MNOV) Medicinova's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 6.22%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 54.31%.
Medicinova's earnings in 2025 is -$11,812,136.On average, 1 Wall Street analyst forecast MNOV's earnings for 2025 to be -$14,713,874, with the lowest MNOV earnings forecast at -$14,713,874, and the highest MNOV earnings forecast at -$14,713,874.
In 2026, MNOV is forecast to generate -$16,185,261 in earnings, with the lowest earnings forecast at -$16,185,261 and the highest earnings forecast at -$16,185,261.